𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) FOR IMPROVED SURVIVAL WITH SECOND-LINE TREATMENT OPTIONS, IN PATIENTS WITH METASTATIC HORMONEREFRACTORY PROSTATE CANCER (MHRPC) PREVIOUSLY TREATED WITH DOCETAXEL

✍ Scribed by M Mason; N Freemantle; A Parnaby; D Högberg


Book ID
118614109
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
75 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.